arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Inventiva S.A.

IVA Health Care Biotechnology: Pharmaceutical Preparations
$4.78
Today
as of Sep 4, 16:50 ET
Last 30 days +3.91% Jul 27 → Sep 04
$4.20 $4.39 $4.58 $4.76 $4.95 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$4.63
High
$4.82
Low
$4.60
Volume
$1M
Avg Vol
$528,131
Mkt Cap
$1.1B
P/E (TTM)
—
Beta
—
52w High
$7.98
52w Low
$3.35
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 10 items

Sep 2 · 21:44 MT Newswires
Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study
Sep 2 · 20:05 PR GlobeNewswire
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
Aug 31 · 22:08 Exec Edge
Chris Benecchi Named Inventiva’s New Chief Operating Officer
▸ Show all 10 press releases & news Free account →

Overview

52-week range
$3.35
$7.98
31% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
469%
EM ±73.2% · $5 · Sep 18

Earnings trends

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Fri Sep 25, 2026Jun/2026AMC -$0.20—

Implied volatility — last 90 days

38%460%883%1305%1728% Jun 15 — IV 1728% · EM ±125.0%Jun 24 — IV 794% · EM ±159.0%Jun 25 — IV 744% · EM ±145.7%Jul 07 — IV 524% · EM ±69.2%Jul 20 — IV 513% · EM ±121.2%Jul 21 — IV 38% · EM ±8.9%Jul 22 — IV 125% · EM ±28.6%Jul 23 — IV 128% · EM ±28.8%Jul 24 — IV 66% · EM ±14.6%Jul 27 — IV 318% · EM ±66.3%Jul 28 — IV 84% · EM ±17.2%Jul 29 — IV 100% · EM ±20.0%Jul 31 — IV 437% · EM ±83.7%Aug 03 — IV 482% · EM ±85.5%Aug 05 — IV 70% · EM ±11.7%Aug 10 — IV 160% · EM ±22.1%Aug 11 — IV 168% · EM ±22.2%Aug 12 — IV 102% · EM ±12.8%Aug 13 — IV 193% · EM ±22.8%Aug 17 — IV 166% · EM ±13.8%Aug 24 — IV 423% · EM ±88.3%Aug 25 — IV 47% · EM ±9.6%Aug 26 — IV 41% · EM ±8.3%Aug 28 — IV 400% · EM ±76.5%Sep 02 — IV 434% · EM ±72.4%Sep 03 — IV 141% · EM ±22.7%Sep 04 — IV 469% · EM ±73.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in